Episode
EP421: 60 Year Old Male Aging with Dr Khanh Part 3
- Published
- Jan 17, 2026
- Duration seconds
- 1941
- Processing state
not_requested- Canonical source
- https://drwarrickbishop.com/podcast/episode/1/ep421-60-year-old-male-aging-with-dr-khanh-part-3
Actions
POST https://stenobird.com/v1/public/podcasts/doctor-warrick-bishop-heart-health-903567/episodes/ep421-60-year-old-male-aging-with-dr-khanh-part-3/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/doctor-warrick-bishop-heart-health-903567/ep421-60-year-old-male-aging-with-dr-khanh-part-3.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction: Dr. Warrick Bishop, a cardiologist, author, and CEO of the Healthy Heart Network, hosts this episode featuring Dr. Khan from the Austin Regenerative Therapy Center for their third conversation on anti-aging medicine. In this episode, they conduct a detailed case study analyzing Dr. Bishop's own health metrics and discussing personalized anti-aging interventions, moving beyond general principles to practical clinical application. Key Takeaways: A comprehensive anti-aging assessment begins with an extensive intake form, medical history review, family genetics, and detailed lab panels including hormones, lipoproteins, glucose markers, and inflammatory indicators. Key biomarkers to track include lipoprotein B, hemoglobin A1C, fasting insulin, sex hormones, thyroid function, vitamin D, DHEA, cortisol, homocysteine, and high-sensitivity C-reactive protein (a marker of inflammation linked to coronary disease). Low free testosterone in aging men can be effectively addressed through testosterone replacement therapy (TRT), which has been shown to reduce mortality and prostate cancer risk—contrary to previous misconceptions—and should be considered when PSA levels are normal. Multiple testosterone replacement options exist, including injectable testosterone (intramuscular or subcutaneous twice weekly), pellet insertion, and newer oral forms like Kaseates, with choice depending on individual preference and fertility c…